Literature DB >> 29075908

Are all patients with short segment Hirschsprung's disease equal? A retrospective multicenter study.

Patrick Ho Yu Chung1, Kenneth Kak Yuen Wong2, Paul Kwong Hang Tam2, Michael Wai Yip Leung3, Nicholas Sih Yin Chao4, Kelvin Kam Wing Liu4, Edwin Kin Wai Chan5, Yuk Him Tam5, Kim Hung Lee5.   

Abstract

BACKGROUND/
PURPOSE: Short segment Hirschsprung's disease (HSCR) carries a better prognosis than long segment disease, but the definition of short is controversial. The objective of this study is to determine anatomically the extent of disease involvement that would be associated with a better functional outcome.
METHODS: This is a retrospective multicenter (n = 3) study with patients (≥ 3 years) who had transanal pullthrough operation done for aganglionosis limited to the recto-sigmoid colon were reviewed. The extent of disease involvement and bowel resection was retrieved by reviewing the operative records as well as histopathological reports of the resected specimens. Clinical assessment was performed according to the criteria of a seven-itemed bowel function score (BFS) (maximum score = 20). Manometric assessment was performed with anorectal manometry.
RESULTS: The study period started from 2003 to 45 patients were studied with median age at assessment = 52.0 months and operation = 3.0 months. The disease involvement was categorized into upper sigmoid-descending colon (DC) (n = 8), sigmoid colon (SC) (n = 12), upper rectum (UR) (n = 14) and lower rectum (LR) (n = 11) according to the level of normal biopsy result. There was no significant difference in the age of assessment between the four groups. The median BFSs in the DC, SC, UR and LR were 13, 15, 17 and 17, respectively (p = 0.01). Nine patients from the DC and SC groups reported soiling for more than twice per week. Sub-group analysis comparing patients with and without the entire sigmoid colon resected revealed worse functional outcomes in terms of the incidence of soiling (40.7 vs 22.2%, p = 0.05) and the BFS (14 vs 18, p = 0.04) in the former group. Anorectal manometry did not reveal any significant difference between the four groups, but a higher proportion of patients in the UR and LR groups appeared to have a normal sphincter resting pressure (DC vs SC vs UR vs LR = 62.5 vs 75.0 vs 85.7 vs 80.0%, p = 0.10).
CONCLUSION: Patients with short segment HSCR are not equal at all. HSCR patients with aganglionosis limited to the rectum without the need of removing the entire sigmoid colon have a better bowel control and overall functional score. Less bowel loss and colonic dissection maybe the underlying reasons. Although future studies with a larger sample size and a longer follow-up period are required to validate the results of this study, it has provided a new insight to the current understanding of short segment disease in HSCR.

Entities:  

Keywords:  Aganglionosis; Anorectal manometry; Hirschsprung’s disease; Transanal

Mesh:

Year:  2017        PMID: 29075908     DOI: 10.1007/s00383-017-4202-4

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  22 in total

1.  Anorectal anatomy and physiology.

Authors:  Andrew Barleben; Steven Mills
Journal:  Surg Clin North Am       Date:  2010-02       Impact factor: 2.741

Review 2.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

Review 3.  Hirschsprung disease.

Authors:  Jacob C Langer
Journal:  Curr Opin Pediatr       Date:  2013-06       Impact factor: 2.856

4.  Anal endosonography and bowel function in patients undergoing different types of endorectal pull-through procedures for Hirschsprung disease.

Authors:  Kjetil J Stensrud; Ragnhild Emblem; Kristin Bjørnland
Journal:  J Pediatr Surg       Date:  2015-01-08       Impact factor: 2.545

5.  Bowel function and fecal continence after Soave's trans-anal endorectal pull-through for Hirschsprung's disease: a local experience.

Authors:  Ossama M Zakaria
Journal:  Updates Surg       Date:  2012-03-06

Review 6.  Review of organic causes of fecal incontinence in children: evaluation and treatment.

Authors:  Lusine Ambartsumyan; Samuel Nurko
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-09       Impact factor: 3.869

7.  Defecation disorders in children after surgery for Hirschsprung disease.

Authors:  Bruno P Chumpitazi; Samuel Nurko
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-07       Impact factor: 2.839

8.  Bowel function and gastrointestinal quality of life among adults operated for Hirschsprung disease during childhood: a population-based study.

Authors:  Kristiina Jarvi; Elina M Laitakari; Antti Koivusalo; Risto J Rintala; Mikko P Pakarinen
Journal:  Ann Surg       Date:  2010-12       Impact factor: 12.969

9.  Outcome of primary endorectal pull-through for the treatment of classic Hirschsprung disease.

Authors:  Girolamo Mattioli; Alessio Pini Prato; Camilla Giunta; Stefano Avanzini; Mirta Della Rocca; Giovanni Montobbio; Stefano Parodi; Giovanni Rapuzzi; Keith Georgeson; Vincenzo Jasonni
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2008-12       Impact factor: 1.878

Review 10.  Long-term results of transanal pull-through for Hirschsprung's disease: a meta-analysis.

Authors:  J Zimmer; C Tomuschat; P Puri
Journal:  Pediatr Surg Int       Date:  2016-07-06       Impact factor: 1.827

View more
  2 in total

1.  Long-term outcomes and quality of life of patients with Hirschsprung disease: a systematic review and meta-analysis.

Authors:  Ying Dai; Yongfang Deng; Yan Lin; Runxian Ouyang; Le Li
Journal:  BMC Gastroenterol       Date:  2020-03-12       Impact factor: 3.067

2.  Optimal timing for Soave primary pull-through in short-segment Hirschsprung disease: A meta-analysis.

Authors:  Maggie L Westfal; Ongoly Okiemy; Patrick Ho Yu Chung; Jiexiong Feng; Changgui Lu; Go Miyano; Paul Kwong Hang Tam; Weibing Tang; Kenneth Kak Yuen Wong; Atsuyuki Yamataka; Richard A Guyer; Daniel P Doody; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2021-07-21       Impact factor: 2.545

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.